United States · FDA National Drug Code directory
Oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-649_1ec65e90-ec0e-431f-a985-d7cb39694492
- Product NDC
- 65162-649
- Form
- SUSPENSION
- Composition / generic term
- Oxcarbazepine
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120604
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 300 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CUP, UNIT-DOSE in 1 TRAY (65162-649-48) / 5 mL in 1 CUP, UNIT-DOSE (65162-649-43) · 65162-649-48
- 1 BOTTLE in 1 CARTON (65162-649-78) / 250 mL in 1 BOTTLE · 65162-649-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →